Security Snapshot

Aimei Health Technology Co., Ltd. - Common Shares (AFJK) Institutional Ownership

CUSIP: G01341109

13F Institutional Holders and Ownership History from Q1 2024 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

6

Shares (Excl. Options)

974,405

Price

$11.45

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-18,658
Value change
-$1,150,244
Number of holders
6
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
6,099,609
SEC-reported price per share
$41.54
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • AFJK - Aimei Health Technology Co., Ltd. - Common Shares is tracked under CUSIP G01341109.
  • 6 institutions reported positions in Q1 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 7 to 6 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $1,264,258 to $11,093,498.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 6 institutions filings for Q1 2026.

Open SEC evidence

Security key

G01341109

Latest holder period

Q1 2026

13F holders

6

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
AFJK
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
First Trust Capital Management L.P. 11% $7,480,000 680,000 First Trust Capital Management L.P. 28 Feb 2025
GLAZER CAPITAL, LLC 6.7% $6,663,745 605,795 Glazer Capital, LLC 31 Dec 2024
BERKLEY W R CORP 6.9% +22% $4,742,775 +$911,646 425,361 +24% W. R. Berkley Corporation 30 Jun 2025
Karpus Management, Inc. 1.3% -91% $2,798,989 -$35,910,120 78,075 -93% KARPUS MANAGEMENT, INC. 31 Dec 2025

As of 31 Mar 2026, 6 institutional investors reported holding 974,405 shares of Aimei Health Technology Co., Ltd. - Common Shares (AFJK). This represents 16% of the company’s total 6,099,609 outstanding shares.

13F concentration

Top 12 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
16%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
First Trust Capital Management L.P. 11% 680,000 0% 0.41% $7,731,600
GLAZER CAPITAL, LLC 2.2% 133,744 0% 0.03% $1,521,000
Clear Street Group Inc. 1.4% 83,337 0% 0.01% $947,542
Karpus Management, Inc. 1.3% 77,125 0% 0.03% $888,480
Federation des caisses Desjardins du Quebec 0% 185 0% $4,533
UBS Group AG 0% 14 -99% 0% $343
JPMORGAN CHASE & CO 0% 0 -100% $0
JANE STREET GROUP, LLC 0% 0 -100% $0
Dakota Wealth Management 0% 0 -100% $0
GEODE CAPITAL MANAGEMENT, LLC 0% 0 -100% $0
OSAIC HOLDINGS, INC. 0% 238 0% $5,831
MORGAN STANLEY 0% 50 0% $1,225

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
9
Latest
Q1 2026
Rows shown
1-9 of 9
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 974,405 $11,093,498 -$1,150,244 $11.45 6
2025 Q4 19,751 $1,264,258 -$20,689,756 $64.01 7
2025 Q3 3,847,815 $43,435,993 -$839,152 $11.32 17
2025 Q2 3,900,428 $43,214,842 -$442,173 $11.07 16
2025 Q1 3,941,452 $43,325,723 -$25,295,273 $11.00 16
2024 Q4 6,300,299 $66,966,106 -$4,771,373 $10.70 23
2024 Q3 6,806,994 $71,329,083 +$1,170,036 $10.48 31
2024 Q2 6,529,401 $67,561,399 +$657,851 $10.35 30
2024 Q1 6,469,886 $66,184,452 +$63,118,452 $10.22 26
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .